{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:16:58Z","timestamp":1787026618547,"version":"build-2736575974"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      X-linked lymphoproliferative disease type 1 (XLP1) is an inborn error of immunity (IEI) caused by pathogenic variants in the\n                      <jats:italic>SH2D1A<\/jats:italic>\n                      gene, leading to severe immune dysregulation, often triggered by Epstein-Barr virus (EBV) infection. Hemophagocytic lymphohistiocytosis (HLH) is one of the most severe manifestations of XLP1 with high mortality.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      Present a clinical case of fatal HLH associated with a novel\n                      <jats:italic>SH2D1A<\/jats:italic>\n                      variant, highlighting the variability of clinical presentation and the potential role of co-infections.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed clinical and laboratory data of three brothers who died from HLH in early age. Genetic evaluation was performed using a 576-gene panel for IEI (Veritas, Spain, supported by the Jeffrey Modell Foundation). Alive siblings and parents were tested in Scientific Medical Genetic Center LeoGENE, Ukraine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A 1-year-old boy was admitted with a persistent 4-day fever and clinical signs of hepatosplenomegaly, anemia, neutropenia, hypertransaminasemia, and hypoproteinemia. Immunophenotyping revealed decreased CD4, increased CD8 T cells, reduced NK cell counts, and elevated immunoglobulin levels. This patient demonstrated high EBV viremia and positive serological markers for SARS-CoV-2. Despite intensive treatment, HLH progressed rapidly, leading to fatality within 35 days. Genetic testing identified a novel, likely pathogenic hemizygous\n                      <jats:italic>SH2D1A<\/jats:italic>\n                      variant, c.175delC (p.Thr59Glnfs*22), not previously reported in affected individuals or the gnomAD database. Family history shows that two older male siblings died at 11 months and 1 year 9 months from a rapidly developed disease presented by fever, hepatosplenomegaly, dermatitis, enterocolitis, anemia, thrombocytopenia, and hypertransaminasemia. The second affected sibling tested positive for EBV serology. The family also included a healthy sister and brother, both with positive EBV serology (IgG) but no detectable viremia. Carrier testing confirmed that the mother and sister are heterozygous carriers, while two male siblings (one of them was born 1 month ago) are unaffected.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      We identified a novel\n                      <jats:italic>SH2D1A<\/jats:italic>\n                      variant associated with fatal HLH in XLP1. Our findings highlight the importance of early genetic diagnosis before EBV exposure to improve patient outcomes. The potential role of co-infections, including SARS-CoV-2, in triggering HLH in XLP1 remains an area for further investigation.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1602107","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T01:14:14Z","timestamp":1747617254000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Fatal HLH in patients with X-linked lymphoproliferative disease 1 due to a novel variant in SH2D1A: case report"],"prefix":"10.3389","volume":"16","author":[{"given":"Oksana","family":"Boyarchuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alla","family":"Volokha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nataliia","family":"Yarema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Dyvoniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetyana","family":"Tomashivska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivanna","family":"Shymanska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halyna","family":"Makukh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolan E.","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-2896.2005.00230.x","article-title":"Molecular and cellular pathogenesis of X-linked lymphoproliferative disease","volume":"203","author":"Nichols","year":"2005","journal-title":"Immunol Rev"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-014-0083-7","article-title":"XLP: clinical features and molecular etiology due to mutations in SH2D1A encoding SAP","volume":"34","author":"Tangye","year":"2014","journal-title":"J Clin Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1056\/nejm197410032911415","article-title":"Letter: Fatal infectious mononucleosis in familial lymphohistiocytosis","volume":"291","author":"Purtilo","year":"1974","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/2424","article-title":"Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene","volume":"20","author":"Coffey","year":"1998","journal-title":"Nat Genet"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1084\/jem.192.3.337","article-title":"X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells","volume":"192","author":"Parolini","year":"2000","journal-title":"J Exp Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12887-019-1444-4","article-title":"Rare cause of Hemophagocytic Lymphohistiocytosis due to mutation in PRF1 and SH2D1A genes in two children \u2013 a case report with a review","volume":"19","author":"Sheth","year":"2019","journal-title":"BMC Pediatr"},{"key":"B7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12881-017-0376-9","article-title":"Characterization of a novel disease-causing mutation in exon 1 of SH2D1A gene through amplicon sequencing: a case report on HLH","volume":"18","author":"Zhou","year":"2017","journal-title":"BMC Med Genet"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1177\/1751143719893865","article-title":"Haemophagocytic lymphohistiocytosis in adult critical care","volume":"21","author":"Bauchmuller","year":"2020","journal-title":"J Intens Care Soc"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-024-01182-6","article-title":"Immunopathology of and potential therapeutics for secondary hemophagocytic lymphohistiocytosis\/macrophage activation syndrome: a translational perspective","volume":"56","author":"Nguyen","year":"2024","journal-title":"Exp Mol Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.5045\/br.2021.2020323","article-title":"Current status of the diagnosis and treatment of hemophagocytic lymphohistiocytosis in adults","volume":"56","author":"Kim","year":"2021","journal-title":"Blood Res"},{"key":"B11","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1182\/blood-2010-06-284935","article-title":"X-linked lymphoproliferative disease due to SAP\/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease","volume":"117","author":"Booth","year":"2011","journal-title":"Blood"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2015.30","article-title":"ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e28184","DOI":"10.1002\/pbc.28184","article-title":"Diagnostic challenges for a novel SH2D1A mutation associated with X-linked lymphoproliferative disease","volume":"67","author":"Torralba-Raga","year":"2020","journal-title":"Pediatr Blood Cancer"},{"key":"B14","article-title":"Correlation of mutations of the SH2D1A gene and epstein-barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease","volume":"96","author":"Sumegi","year":"2000","journal-title":"Blood"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197402142900704","article-title":"Fatal infectious mononucleosis in a family","volume":"290","author":"Bar","year":"1974","journal-title":"N Engl J Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197507102930202","article-title":"Acquired agammaglobulinemia after a life-threatening illness with clinical and laboratory features of infectious mononucleosis in three related male children","volume":"293","author":"Provisor","year":"1975","journal-title":"N Engl J Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-106-4-538","article-title":"Epstein\u2013Barr virus infections in males with the X-linked lymphoproliferative syndrome","volume":"106","author":"Grierson","year":"1987","journal-title":"Ann Intern Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00666","article-title":"X-linked lymphoproliferative disease type 1: A clinical and molecular perspective","volume":"9","author":"Panchal","year":"2018","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.794110","article-title":"Fatal SARS in X-linked lymphoproliferative disease type 1: A case report","volume":"10","author":"Chung","year":"2022","journal-title":"Front Pediatr"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2023.1086867","article-title":"Case report: Virus-induced hemophagocytic lymphohistiocytosis in a patient with APECED","volume":"11","author":"Boyarchuk","year":"2023","journal-title":"Front Pediatr"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2023.1222522","article-title":"Editorial: Macrophage activation syndrome in children in the era of COVID-19","volume":"11","author":"Boyarchuk","year":"2023","journal-title":"Front Pediatr"},{"key":"B22","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s10875-024-01701-0","article-title":"Single-cell transcriptomic analysis of epstein-barr virus-associated hemophagocytic lymphohistiocytosis","volume":"44","author":"Suzuki","year":"2024","journal-title":"J Clin Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e30951","DOI":"10.1097\/MD.0000000000030951","article-title":"Potential pathogenic mechanism of type 1 X-linked lymphoproliferative syndrome caused by a mutation of SH2D1A gene in an infant: A case report","volume":"101","author":"Wang","year":"2022","journal-title":"Med (Baltimore)"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-199510000-00001","article-title":"X-linked lymphoproliferative disease: twenty-five years after the discovery","volume":"38","author":"Seemayer","year":"1995","journal-title":"Pediatr Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01740","article-title":"Current flow cytometric assays for the screening and diagnosis of primary HLH","volume":"10","author":"Chiang","year":"2019","journal-title":"Front Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1084\/jem.20042432","article-title":"Defective NKT cell development in mice and humans lacking the adapter SAP, the X-linked lymphoproliferative syndrome gene product","volume":"201","author":"Pasquier","year":"2005","journal-title":"J Exp Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.5114\/polp.2018.77435","article-title":"Physicians\u2019 awareness concerning primary immunodeficiencies in the Ternopil Region of Ukraine","volume":"93","author":"Boyarchuk","year":"2018","journal-title":"Pediatr Polska - Polish J Paediatr"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1602107\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T01:14:15Z","timestamp":1747617255000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1602107\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,19]]},"references-count":28,"alternative-id":["10.3389\/fimmu.2025.1602107"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1602107","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,19]]},"article-number":"1602107"}}